Joel Michael Maryles Chemomab Therapeutics Ltd. (CMMB) insider trading activity
Joel Michael Maryles is Director of Chemomab Therapeutics Ltd.. Currently has a direct ownership of 1,433 shares of CMMB, which is worth approximately $2,364. The most recent transaction as insider was on May 24, 2022, when has been sold 433 shares (American Depositary Shares) at a price of $2.83 per share, resulting in proceeds of $1,225. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.43K
0%
3M change
0%
12M change
Total Value Held
$2,364
Joel Michael Maryles Transaction History
JMM
Joel Michael Maryles
Director
Hashmonaim, L3